Maple Capital Management Inc. Has $17.73 Million Holdings in CME Group Inc. $CME

Maple Capital Management Inc. grew its holdings in CME Group Inc. (NASDAQ:CME) by 0.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,337 shares of the financial services provider’s stock after buying an additional 449 shares during the period. CME Group accounts for about 1.2% of Maple Capital Management Inc.’s portfolio, making the stock its 28th biggest holding. Maple Capital Management Inc.’s holdings in CME Group were worth $17,733,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. GQG Partners LLC lifted its holdings in CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after purchasing an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock worth $704,068,000 after buying an additional 2,089,935 shares during the period. Nuveen LLC acquired a new position in CME Group in the 1st quarter valued at about $218,842,000. Alliancebernstein L.P. raised its holdings in CME Group by 185.5% in the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after acquiring an additional 808,740 shares during the period. Finally, Egerton Capital UK LLP boosted its holdings in shares of CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock worth $459,003,000 after acquiring an additional 765,773 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently weighed in on CME shares. Argus dropped their price target on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. UBS Group decreased their price target on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. Jefferies Financial Group lowered their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Keefe, Bruyette & Woods increased their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $286.06.

CME Group Trading Up 0.6%

CME opened at $278.84 on Wednesday. The stock has a market capitalization of $100.55 billion, a price-to-earnings ratio of 27.02, a P/E/G ratio of 4.41 and a beta of 0.38. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $222.56 and a twelve month high of $290.79. The company has a 50-day simple moving average of $266.34 and a 200 day simple moving average of $272.60.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.68 EPS. Analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Insider Buying and Selling

In other news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 14,043 shares of company stock worth $3,791,486. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.